These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 3496407)
21. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592 [TBL] [Abstract][Full Text] [Related]
22. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340 [TBL] [Abstract][Full Text] [Related]
23. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor. Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601 [TBL] [Abstract][Full Text] [Related]
24. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Mazzucato M; De Marco L; Pradella P; Masotti A; Pareti FI Thromb Haemost; 1996 Apr; 75(4):655-60. PubMed ID: 8743195 [TBL] [Abstract][Full Text] [Related]
25. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Andrews RK; Harris SJ; McNally T; Berndt MC Biochemistry; 1998 Jan; 37(2):638-47. PubMed ID: 9425086 [TBL] [Abstract][Full Text] [Related]
26. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Ikeda Y; Handa M; Kamata T; Kawano K; Kawai Y; Watanabe K; Kawakami K; Sakai K; Fukuyama M; Itagaki I Thromb Haemost; 1993 May; 69(5):496-502. PubMed ID: 8391728 [TBL] [Abstract][Full Text] [Related]
27. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708 [TBL] [Abstract][Full Text] [Related]
28. The interaction of von Willebrand factor (vWf) with collagen: investigation of vWf-binding sites in the collagen molecule. Fitzsimmons CM; Cockburn CG; Hornsey V; Prowse CV; Barnes MJ Thromb Haemost; 1988 Apr; 59(2):186-92. PubMed ID: 3260414 [TBL] [Abstract][Full Text] [Related]
29. Proteolytic and immunologic comparison of human and bovine von Willebrand factor. Bakhshi MR; Kirby EP Thromb Haemost; 1990 Jun; 63(3):517-23. PubMed ID: 2205950 [TBL] [Abstract][Full Text] [Related]
30. Proteolytic studies on the structure of bovine von Willebrand factor. Mascelli MA; Kirby EP Biochemistry; 1988 Feb; 27(4):1274-84. PubMed ID: 2452652 [TBL] [Abstract][Full Text] [Related]
31. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain. Girma JP; Chopek MW; Titani K; Davie EW Biochemistry; 1986 Jun; 25(11):3156-63. PubMed ID: 3015200 [TBL] [Abstract][Full Text] [Related]
32. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Fay PJ; Kawai Y; Wagner DD; Ginsburg D; Bonthron D; Ohlsson-Wilhelm BM; Chavin SI; Abraham GN; Handin RI; Orkin SH Science; 1986 May; 232(4753):995-8. PubMed ID: 3486471 [TBL] [Abstract][Full Text] [Related]
33. Evidence for a factor promoting the conversion of VWF from low and intermediate to high molecular mass polymers on the platelet membrane. Ferri A; Guerra S; Gemmati D; Chiozzi P FEBS Lett; 1989 Jun; 249(2):362-6. PubMed ID: 2786819 [TBL] [Abstract][Full Text] [Related]
34. von Willebrand factor and cancer: a renewed interest. Franchini M; Frattini F; Crestani S; Bonfanti C; Lippi G Thromb Res; 2013 Apr; 131(4):290-2. PubMed ID: 23394808 [TBL] [Abstract][Full Text] [Related]
35. Abnormal platelet von Willebrand factor (vWF) as a marker of abnormal function in megakaryocytic dysplasia. de Cataldo F; Baudo F; Redaelli R; Corno AR Am J Hematol; 1995 Mar; 48(3):155-7. PubMed ID: 7864022 [TBL] [Abstract][Full Text] [Related]
37. Normal binding of plasma von Willebrand factor to platelets in essential thrombocythemia. van Genderen PJ; Leenknegt H Am J Hematol; 1999 Jun; 61(2):153-4. PubMed ID: 10367798 [No Abstract] [Full Text] [Related]
38. Modification of the platelet-binding domain of von Willebrand factor. Silverman C; Mascelli MA; Karl DW; Kirby EP J Lab Clin Med; 1987 Jul; 110(1):113-8. PubMed ID: 3496407 [TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of von Willebrand disease. Mazurier C; Ribba AS; Gaucher C; Meyer D Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650 [TBL] [Abstract][Full Text] [Related]
40. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains. Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]